Dupilumab combined with a short-term narrowbandultraviolet B phototherapy in a pediatric case of severe atopic dermatitis
Recently, dupilumab treatment in atopic dermatitis (AD) has been an effective and safe option in terms of adverse effects. However, combination therapies can sometimes be better at increasing efficacy or reducing adverse effects or cumulative doses. Early combination therapies may be more rational,...
Saved in:
Main Authors: | Ayşe Kavak (Author), Çiğdem Aydoğmuş (Author), Kübra Yılmaz (Author) |
---|---|
Format: | Book |
Published: |
Galenos Publishing House,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combination Therapy of Oral Tofacitinib with Phototherapy in Severe Pediatric Atopic Dermatitis
by: Ananya Pramanik, et al.
Published: (2024) -
Efficacy of dupilumab in moderate and severe atopic dermatitis
by: Stephan Weidinger, et al.
Published: (2023) -
Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab
by: Shoko Miyamoto, et al.
Published: (2022) -
Eye Complications During Dupilumab Treatment for Severe Atopic Dermatitis
by: Lina U. Ivert, et al.
Published: (2019) -
Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
by: Maria Esposito, MD, et al.
Published: (2023)